The Federal Competition and Consumer Protection Commission (FCCPC), has commenced an inquiry into the high cost and variation in the prices of drugs in the country. Executive Vice Chairman of the Commission, Mr Tunji Bello, said at the opening of the inquiry with pharmaceutical and healthcare stakeholders in Abuja, yesterday, that the inquiry was in […] The post FCCPC begins inquiry into high cost of BP, diabetes medications appeared first on The Sun Nigeria.
The Federal Competition and Consumer Protection Commission (FCCPC) has initiated an inquiry into the high costs and price variations of blood pressure and diabetes medications. Led by Mr. Tunji Bello, the inquiry aims to identify factors affecting healthcare accessibility and affordability. Consumer complaints about price disparities and high costs have highlighted the issue, with 70% of raw materials being imported, contributing to higher costs through foreign exchange rates and electricity tariffs. The significant rise in medication costs over the past year has made treatment difficult for many, underscoring the inquiry's importance.
